microbe solutions for wellness and balance
Millions of people face modern wellness challenges — from changes in skin and energy to shifts in body composition and overall well-being — which emerging research suggests may be associated with alterations in key gut microbes linked to modern diets, lifestyles, and medications.
We take a research-driven approach to the human microbiome — including our proprietary L. reuteri LRDR™ strain — to help support balanced body composition, overall wellness, and a healthy appearance.
Our MISSION is to help people achieve better well-being and body composition.
specific microbes coupled with other nutrients that modulate microbiome composition
Based on Dr. Davis's work, Realize develops microbiome-based wellness solutions — centered on our proprietary L. reuteri LRDR™ strain — paired with complementary nutrients in a novel approach to help support the body's natural balance and overall well-being.
William Davis, MD, Co-Founder & CMO,
is a cardiologist and expert in gut and heart health, with 25 years of clinical experience and is an expert in the field of omega-3 fatty acids, vitamin D, and the human microbiome. A leading advocate of nutrition and proponent of wheat and grain elimination, thousands have adopted Dr. Davis's gut-health and microbiome-based approach. Individual results may vary.
Dr. Davis's research into 'keystone' gut microbes led to the development of a unique Lactobacillus reuteri strain — now LRDR™ — and investigation of how it may support microbiome balance, body composition, and overall well-being.
Mark Nottoli, Co-Founder & CEO
Mark Nottoli, Co-Founder & CEO, is a serial entrepreneur, innovator and investor in the healthcare space with numerous exits. Passionate about applied science, Mark has repeatedly licensed intellectual property from academic institutions and globally commercialized novel nutrition products. Inspired to develop novel health solutions, he is dedicated to advancing Realize Therapeutics worldwide.
Important Notice: Educational & informational only. LRDR is investigational and not intended to diagnose, treat, cure, or prevent disease. Findings are preliminary & subject to validation. Individual responses vary. Consult a healthcare professional. Not evaluated by the FDA.
notify me of new developments
Keep up to date with new developments from Realize Therapeutics